Determining specific gene alterations that act as markers of progression such as SPINK1, PRSS1 and CFTR
ClinicalTrials.gov, the registry where any legitimate trial must appear before enrollment, returns zero studies for the compound, and no trial report exists in the PubMed literature
Our guide on foods to avoid on semaglutide covers specific triggers
Its also important, though, to communicate with your healthcare provider about any side effects youre experiencing so they can work with you to find the right dose
As patients and clinicians navigate treatment with this newer agent, questions arise about its composition and potential nutritional implications
This weight regain is not a sign of personal failure or a rebound effect unique to the drug